Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:11:1781-7.
doi: 10.1100/2011/409140. Epub 2011 Oct 19.

Pregnancy rates with recombinant versus urinary human chorionic gonadotropin in in vitro fertilization: an observational study

József Zeke  1 , Katalin Kanyó, Helga Zeke, Aron Cseh, Barna Vásárhelyi, András Szilágyi, János Konc
Affiliations

Pregnancy rates with recombinant versus urinary human chorionic gonadotropin in in vitro fertilization: an observational study

József Zeke et al. ScientificWorldJournal. 2011.

Abstract

Randomized clinical trials (RCTs) demonstrated the equal efficacy of urinary human chorionic gonadotropin (uhCG) and recombinant hCG (rhCG) products in in vitro fertilisation (IVF). However, limitations inherent with RCTs necessitate the reinforcement of RCT results in real-life. We retrospectively analyzed pregnancies after treatment with rhCG and uhCG products (n = 391, and 96, resp.). We found that laboratory-verified pregnancy occurred more frequently in rhCG patients than in those on uhCG (43% versus 30%, P = 0.02). The association remains significant (P = 0.002) after its adjustment for clinical characteristics. The prevalence of laboratory-verified pregnancies was higher with GnRH agonist use (P = 0.012) and BMI under 30 kg/m(2) (P = 0.053) while decreased the age (P = 0.014) and the number of previous failed attempts (P = 0.08). Similar (but not significant) trends were observed with rates of pregnancy filled the 24th week. These results reinforce RCTs supporting the notion that rhCG is more efficient as uhCG during IVF.

Keywords: assisted reproduction; laboratory-verified pregnancy; recombinant hCG; urinary hCG.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The selection of patients for our study.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertility and Sterility. 2003;79(5):1051–1059. - PubMed
    1. Al-Inany HG, Aboulghar M, Mansour R, Proctor M. Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception. Cochrane Database of Systematic Reviews. 2005;2 Article ID CD003719. - PubMed
    1. Farrag A, Costantini A, Manna C, Grimaldi G. Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI. Journal of Assisted Reproduction and Genetics. 2008;25(9-10):461–466. - PMC - PubMed
    1. Kovacs P, Kovats T, Bernard A, Zadori J, Szmatona G, Kaali SG. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization. Fertility and Sterility. 2008;90(6):2133–2137. - PubMed
    1. Papanikolaou EG, Bourgain C, Fatemi H, et al. Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study. Reproductive BioMedicine Online. 2010;21(1):50–55. - PubMed

Substances